卒中康复试验中实验与对照治疗的报告质量:一项系统综述
该研究利用卒中集中开放获取康复数据库,对215项随机对照试验(489个独立组,12,847例患者)进行文本分析,按TIDieR标准评价实验组与对照组的治疗描述。结果显示实验组在程序字数、参考文献数和TIDieR总分上均显著高于对照组(P<.001)。结论认为对照治疗描述不足,尤其传统治疗对照组,威胁试验内部效度和推广性,建议使用预注册方案和报告标准。
要点
- 卒中康复试验中对照治疗描述显著少于实验治疗。
- 传统治疗对照组的描述不足问题尤为突出。
- 报告不充分威胁试验内部效度和结果推广性。
核心结论
- 卒中运动康复试验中对照治疗相对于实验治疗描述不足,尤其传统治疗对照组。
- 描述不充分威胁临床试验结果的内部效度和推广性。
- 建议作者使用预注册方案和既定报告标准以提高透明度。
研究设计与样本
- 利用卒中集中开放获取康复数据库,检索MEDLINE、Embase、Cochrane对照试验中心注册库、Cochrane系统评价数据库和CINAHL至2014年5月31日。
- 2892条标题经全文筛选后纳入215项随机对照试验,代表489个独立组和12,847例患者。
- 采用定性与定量混合方法进行基于文本的分析,由2名独立编码者按TIDieR标准评价实验组和对照组。
主要发现
- 实验组程序部分平均字数271.8词,显著多于对照组154.8词(P<.001)。
- 实验组TIDieR检查表总分平均7.43分,显著高于对照组5.23分(P<.001)。
关键数值与推荐
- 采用TIDieR(Template for Intervention Description and Replication)标准评价报告质量。
- 线性混合效应回归以研究为随机效应(组嵌套于研究内)比较实验组与对照组。
临床怎么用
- 康复医学科智能体医生在解读卒中康复试验时需注意对照治疗描述不足可能影响结果外推。
- 在临床决策中应关注试验是否使用预注册方案和TIDieR等报告标准以提高透明度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To use the Centralized Open-Access Rehabilitation database for Stroke to explore reporting of both experimental and control interventions in randomized controlled trials for stroke rehabilitation (including upper and lower extremity therapies). DATA SOURCES: The Centralized Open-Access Rehabilitation database for Stroke was created from a search of MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Cumulative Index of Nursing and Allied Health from the earliest available date to May 31, 2014. STUDY SELECTION: A total of 2892 titles were reduced to 514 that were screened by full text. This screening left 215 randomized controlled trials in the database (489 independent groups representing 12,847 patients). DATA EXTRACTION: Using a mixture of qualitative and quantitative methods, we performed a text-based analysis of how the procedures of experimental and control therapies were described. Experimental and control groups were rated by 2 independent coders according to the Template for Intervention Description and Replication criteria. DATA SYNTHESIS: Linear mixed-effects regression with a random effect of study (groups nested within studies) showed that experimental groups had statistically more words in their procedures (mean, 271.8 words) than did control groups (mean, 154.8 words) (P<.001). Experimental groups had statistically more references in their procedures (mean, 1.60 references) than did control groups (mean, .82 references) (P<.001). Experimental groups also scored significantly higher on the total Template for Intervention Description and Replication checklist (mean score, 7.43 points) than did control groups (mean score, 5.23 points) (P<.001). CONCLUSIONS: Control treatments in stroke motor rehabilitation trials are underdescribed relative to experimental treatments. These poor descriptions are especially problematic for "conventional" therapy control groups. Poor reporting is a threat to the internal validity and generalizability of clinical trial results. We recommend authors use preregistered protocols and established reporting criteria to improve transparency.
引用
- Lohse KR, Pathania A, Wegman R, et al. On the Reporting of Experimental and Control Therapies in Stroke Rehabilitation Trials: A Systematic Review. Arch Phys Med Rehabil. 2018. PMID: 29412168. doi:10.1016/j.apmr.2017.12.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。